Glaukos Corp (GKOS)
98.91
+2.91
(+3.03%)
USD |
NYSE |
May 01, 16:00
98.82
-0.09
(-0.09%)
Pre-Market: 20:00
Glaukos Research and Development Expense (Quarterly): 39.06M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.06M |
| September 30, 2023 | 33.30M |
| June 30, 2023 | 36.23M |
| March 31, 2023 | 35.17M |
| December 31, 2022 | 35.81M |
| September 30, 2022 | 28.87M |
| June 30, 2022 | 41.71M |
| March 31, 2022 | 26.88M |
| December 31, 2021 | 26.68M |
| September 30, 2021 | 33.85M |
| June 30, 2021 | 29.26M |
| March 31, 2021 | 21.22M |
| December 31, 2020 | 21.24M |
| September 30, 2020 | 20.30M |
| June 30, 2020 | 18.97M |
| March 31, 2020 | 24.87M |
| December 31, 2019 | 20.03M |
| September 30, 2019 | 18.78M |
| June 30, 2019 | 19.31M |
| March 31, 2019 | 13.93M |
| Date | Value |
|---|---|
| December 31, 2018 | 12.96M |
| September 30, 2018 | 13.20M |
| June 30, 2018 | 12.61M |
| March 31, 2018 | 10.91M |
| December 31, 2017 | 10.52M |
| September 30, 2017 | 9.805M |
| June 30, 2017 | 14.95M |
| March 31, 2017 | 8.942M |
| December 31, 2016 | 7.399M |
| September 30, 2016 | 7.807M |
| June 30, 2016 | 6.955M |
| March 31, 2016 | 7.062M |
| December 31, 2015 | 6.295M |
| September 30, 2015 | 6.173M |
| June 30, 2015 | 7.339M |
| March 31, 2015 | 5.24M |
| December 31, 2014 | 5.308M |
| September 30, 2014 | 5.093M |
| June 30, 2014 | 4.422M |
| March 31, 2014 | 4.383M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
18.78M
Minimum
Sep 2019
41.71M
Maximum
Jun 2022
27.98M
Average
26.88M
Median
Mar 2022
Research and Development Expense (Quarterly) Benchmarks
| Integer Holdings Corp | 15.75M |
| Globus Medical Inc | 52.25M |
| PROCEPT BioRobotics Corp | 14.50M |
| Alphatec Holdings Inc | 22.28M |
| Asensus Surgical Inc | 8.614M |